CV Sciences, Inc. (OTCMKTS:CVSI – Get Free Report) saw a large decline in short interest in the month of April. As of April 30th, there was short interest totaling 15,330 shares, a decline of 81.3% from the April 15th total of 82,061 shares. Based on an average trading volume of 2,095,890 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the company’s shares are sold short.
CV Sciences Stock Up 3.4%
OTCMKTS:CVSI traded up $0.00 during mid-day trading on Thursday, hitting $0.03. 128,761 shares of the company’s stock traded hands, compared to its average volume of 924,705. The company has a fifty day moving average of $0.04 and a 200 day moving average of $0.04. The company has a current ratio of 1.03, a quick ratio of 0.21 and a debt-to-equity ratio of 0.26. CV Sciences has a twelve month low of $0.02 and a twelve month high of $0.10.
CV Sciences Company Profile
CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.
Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.
Read More
- Five stocks we like better than CV Sciences
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
